Protara Therapeutics, Inc. Deferred Tax Liabilities, Tax Deferred Income
Protara Therapeutics, Inc. (TARA) had Deferred Tax Liabilities, Tax Deferred Income of $322.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesTaxDeferredIncome · last filed 2021-03-11
- 2020-12-31: Deferred Tax Liabilities, Tax Deferred Income $322.00K.
- 2019-12-31: Deferred Tax Liabilities, Tax Deferred Income $2.00K.
| Period end | Deferred Tax Liabilities, Tax Deferred Income |
|---|---|
| 2020-12-31 | $322.00K 10-K · filed 2021-03-11 |
| 2019-12-31 | $2.00K 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |